SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,460,000 | +1.4% | 400,000 | 0.0% | 0.09% | -2.3% |
| Q2 2017 | $4,400,000 | +534.9% | 400,000 | +523.8% | 0.09% | +252.0% |
| Q4 2016 | $693,000 | -81.6% | 64,127 | -82.6% | 0.02% | -78.4% |
| Q3 2016 | $3,770,000 | +8.5% | 367,800 | +38.3% | 0.12% | +1.8% |
| Q2 2016 | $3,474,000 | +0.7% | 265,971 | -15.2% | 0.11% | +15.2% |
| Q1 2016 | $3,450,000 | +31.6% | 313,637 | +10.2% | 0.10% | +59.7% |
| Q4 2015 | $2,621,000 | +144.7% | 284,545 | +84.5% | 0.06% | +82.4% |
| Q3 2015 | $1,071,000 | -69.9% | 154,266 | -57.5% | 0.03% | -64.9% |
| Q2 2015 | $3,564,000 | -5.9% | 362,898 | -15.1% | 0.10% | +1.0% |
| Q1 2015 | $3,787,000 | -28.9% | 427,472 | -29.0% | 0.10% | -17.9% |
| Q4 2014 | $5,328,000 | +8.5% | 601,891 | -15.4% | 0.12% | +4.5% |
| Q3 2014 | $4,911,000 | +340.1% | 711,369 | +221.3% | 0.11% | +300.0% |
| Q4 2013 | $1,116,000 | -35.7% | 221,369 | -35.3% | 0.03% | -28.2% |
| Q3 2013 | $1,735,000 | +325.2% | 342,136 | +316.0% | 0.04% | +254.5% |
| Q2 2013 | $408,000 | – | 82,251 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|